Tobacco Use DisorderStPaulKoreaNCT01323725
Team-based Financial Incentives for Smoking Cessation
A study testing Team-based financial incentives in people with Tobacco Use Disorder, run by St.Paul's Hospital, Korea at 1 site in South Korea.
Trial summary
The purpose of this study is to identify the effectiveness of team-base financial incentives for increasing long-term smoking cessation among employees at St. Paul's Hospital, Korea. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Tobacco Use Disorder
- What is being tested?
- Team-based financial incentives
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 28 participants
- Where
- 1 siteSouth Korea
- Study dates
- Jan 2011to Dec 2011
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Employees of St. Paul's Hospital at work sites in Korea
- Current smoker who report having smoked at least 5 cigarettes per day for the prior 12 months
- Age 18 or older
Who cannot join
- Age 17 or younger
- Unwilling to quit smoking
- Smoker who does not want to be enrolled in this trial
- Planning to leave St. Paul's hospital within the next 12 months
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effectiveness of Team-based Financial Incentives for Increasing Long-term Smoking Cessation
The purpose of this study is to identify the effectiveness of team-base financial incentives for increasing long-term smoking cessation among employees at St. Paul's Hospital, Korea.
Read the detailed description
About 70% of smokers report that they want to quit, but annually 2 to 3% of smokers succeed. Smoking-cessation programs and pharmacologic therapies have been proven effective in helping smokers quit, but only a few smokers are enrolled in those programs.
Financial incentives may contribute to reinforce smoking cessation among workers through the following pathways: (1) increasing the number of tobacco users who participate in cessation effort; (2) increasing the number of tobacco user who initiate an attempt to quit; and (3) increasing the number of tobacco users who sustain a successful quit effort. Moreover, there is a number of advantages to offering smoking cessation support in the workplace, including the accessibility of the target population, the availability of occupational health support and the potential for peer pressure and peer support. In addition, team-based approach for smoking cessation could likely make use of new or existing cessation support resources offered within the workplace.
This study is a clinical trial of team-based financial incentives for smoking cessation among a sample of 60 smokers, who are health care workers from St. Paul's Hospital in Korea. Smokers will be given a usual care (counseling, education and coverage of prescription drugs) plus a package of financial incentives for self-reported and biochemically validated smoking cessation (urine or saliva cotinine). All incentives will be provided to each team at 6 months post-quit date.
- Conditions
- Tobacco Use Disorder
- Being tested
- Team-based financial incentives
- Keywords
- Team-based financial incentives, Smoking cessation
- Medical subject headings
- Tobacco Use Disorder, Smoking Cessation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Team-based financial incentivesBehavioural
Team-based financial incentives for smoking cessation at 6 month post-quit date.
| Study group | Role | What they receive |
|---|---|---|
| Team-based financial incentives | Experimental | Team-based financial incentives Receives: Behavioral: Team-based financial incentives |
What is being measured
The primary outcome is the main question the study is designed to answer.
Smoking Cessation Rate
Self-reported and biochemically validated smoking cessation rate at 6 months post-quit date
Measured: 6 months
Secondary outcomes (1)
Smoking Cessation Rate
Self-reported and biochemically validated smoking cessation rate at 3, 9, 12 months post-quit date
Measured: 3, 9, 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Mar 2011 (estimated)
- Study startJan 2011
- Primary completionDec 2011
- Study completionDec 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Tobacco Use DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 28 participants (actual)
Sponsor and investigators
- Lead sponsor
- St.Paul's Hospital, Korea
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sang Haak Lee, St.Paul's Hospital, Korea
- Investigators
- Sang Haak Lee, MD, Principal investigator, St. Paul's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01323725
- Sponsor's protocol ID
- StPaulKorea
- Acronym
- StPaulKorea
- Status last verified
- May 2016
- First submitted
- 25 Mar 2011
- Last updated
- 3 May 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effectiveness of Team-based Financial Incentives for Increasing Long-term Smoking Cessation
- ClinicalTrials.gov ID
- NCT01323725
- Acronym / sponsor ID
- StPaulKorea / StPaulKorea
- Conditions
- Tobacco Use Disorder
- Keywords
- Team-based financial incentives, Smoking cessation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 28 participants (actual)
- Lead sponsor
- St.Paul's Hospital, KoreaUniversity, hospital or other
- Study start
- Jan 2011
- Primary completion
- Dec 2011 (actual)
- Study completion
- Dec 2011 (actual)
- First posted
- 28 Mar 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to identify the effectiveness of team-base financial incentives for increasing long-term smoking cessation among employees at St. Paul's Hospital, Korea.
Detailed description
About 70% of smokers report that they want to quit, but annually 2 to 3% of smokers succeed. Smoking-cessation programs and pharmacologic therapies have been proven effective in helping smokers quit, but only a few smokers are enrolled in those programs.
Financial incentives may contribute to reinforce smoking cessation among workers through the following pathways: (1) increasing the number of tobacco users who participate in cessation effort; (2) increasing the number of tobacco user who initiate an attempt to quit; and (3) increasing the number of tobacco users who sustain a successful quit effort. Moreover, there is a number of advantages to offering smoking cessation support in the workplace, including the accessibility of the target population, the availability of occupational health support and the potential for peer pressure and peer support. In addition, team-based approach for smoking cessation could likely make use of new or existing cessation support resources offered within the workplace.
This study is a clinical trial of team-based financial incentives for smoking cessation among a sample of 60 smokers, who are health care workers from St. Paul's Hospital in Korea. Smokers will be given a usual care (counseling, education and coverage of prescription drugs) plus a package of financial incentives for self-reported and biochemically validated smoking cessation (urine or saliva cotinine). All incentives will be provided to each team at 6 months post-quit date.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Team-based financial incentives | Experimental | Behavioral: Team-based financial incentivesTeam-based financial incentives |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Employees of St. Paul's Hospital at work sites in Korea
- Current smoker who report having smoked at least 5 cigarettes per day for the prior 12 months
- Age 18 or older
Key exclusion criteria (4 listed)
- Age 17 or younger
- Unwilling to quit smoking
- Smoker who does not want to be enrolled in this trial
- Planning to leave St. Paul's hospital within the next 12 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Team-based financial incentivesTeam-based financial incentives for smoking cessation at 6 month post-quit date. | Behavioural | Team-based financial incentives |
Primary outcome
Smoking Cessation Rate
Time frame: 6 months
Self-reported and biochemically validated smoking cessation rate at 6 months post-quit date
1 secondary outcome
Smoking Cessation Rate
Time frame: 3, 9, 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2016.
- Individual participant dataSharing planned: Yes
Related trials for Tobacco Use Disorder
Active, not recruitingPhase 3
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
Tobacco Dependence
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
Recruiting
Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida: The BReATHE Study
Vaping Teens, Vaping Behaviors
Recruiting
Adaptation and Testing of a Novel Text-based Tobacco Cessation and Education Intervention in Kenyan Emergency Department Patients
Tobacco Use, Tobacco Use Cessation
Recruiting
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Tobacco Use, Substance Use Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sang Haak Lee, MD principal investigator
St. Paul's Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Team-based financial incentives in people with Tobacco Use Disorder, run by St.Paul's Hospital, Korea at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 May 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Smoking Cessation Rate (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2016.